Integra Lifesciences Holdings (IART) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Integra Lifesciences Holdings Corp  (NASDAQ: IART)
 

Integra Lifesciences Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Integra Lifesciences Holdings's inventory turnover ratio, the ratio that measures Integra Lifesciences Holdings's ability to manage its supply chain, sequentially decreased to 1.59 in the second quarter 2026, which does not come as a surprise, as the Integra Lifesciences Holdings continue to experience headwinds, which also impact its supply chain. Integra Lifesciences Holdings's average inventory processing period in the Jun 30 2026 quarter, has increased to 230 days, from 224 days, in the Mar 31 2026 quarter.

Within Healthcare sector 250 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 1418.

IART Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Integra Lifesciences Holdings Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IART Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 5.78 % 11.14 % 14.83 % 11.94 % 10.28 %
Y / Y Cost of Sales Growth -3.52 % -7.06 % 10.58 % 8.02 % 7.29 %
Inventory Turnover Ratio (TTM) 1.59 1.63 1.7 1.71 1.73
IART's Total Ranking # 1418 # 1418 # 1257 # 734 # 1444
Average inventory processing period 229 224 215 213 211
Seq. Inventory Growth -0.61 % 0.47 % 0.74 % 5.16 % 4.42 %
Seq. Cost of Sales Growth 13.77 % -18.28 % 9.73 % -5.43 % 9.59 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 251
Overall Market # 1418

Inventory Turnover Ratio Statistics
High Average Low
1.98 1.68 1.27
(Dec 31 2018)   (Dec 31 2011)



IART Company Profile >> Back to IART Efficiency Comparisons >> Compare IART Inventory Turnover Ratio to its Competitors

Financial Statements
Integra Lifesciences Holdings's Inventories $ 492 Millions Visit IART's Balance sheet
Integra Lifesciences Holdings's Cost of Revenues TTM $ 783 Millions Visit IART's Income Statement
What are IART's Sales? Visit IART's Sales by Segment

Other Inventory Turnover Ratios
Integra Lifesciences Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IART's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IART's Competitors
Inventory Turnover Ratio for IART's Suppliers
Inventory Turnover Ratio for IART's Customers

You may also want to know
IART's Sales Growth Rates IART's Pe Price to earnings ratio IART's Receivables Turnover Ratio IART's Stock Quote
IART's Net Income Growth Rates IART's Ps Price to Sales ratio IART's Sales per Employee IART's Asset Turnover Ratio
IART's Net Margin IART's Pb Price to Book ratio IART's Financial Strength Ratios IART's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Agilent Technologies inc   3.17 $ 3,404.000  Millions$ 1,073  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions

Date modified: 2026-08-12T20:13:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.